Influence of MHC CLASS II in Susceptibility to Beryllium Sensitization and Chronic Beryllium Disease

Journal of Immunology

Volumn 171, Issue 12, 2003, Pages 6910-6918

  Maier, Lisa A ^a,b   McGrath, Dierdre S ^c   Sato, Hiroe ^c   Lympany, Penny ^c   Welsh, Ken ^c   Du Bois, Roland ^c   Silveira, Lori ^a   Fontenot, Andrew P ^b   Sawyer, Richard T ^a   Wilcox, Eric ^a   Newman, Lee S ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM; CARBON MONOXIDE; EPITOPE; GENOMIC DNA; GLUTAMIC ACID; HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DPB1; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1; HLA DRB3; HLA DRB4; HLA DRB5; HLA-DPB1; HLA-DRB1; HLA-DRB3; HLA-DRB4; HLA-DRB5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELISM; ARTERIAL OXYGEN TENSION; ARTICLE; BERYLLIOSIS; CASE CONTROL STUDY; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HOMOZYGOSITY; HOSPITALIZATION; HUMAN; IMMUNIZATION; IMMUNOLOGY; LUNG ALVEOLUS OXYGEN TENSION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTICENTER STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIZATION;

EID: 10744224113     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.12.6910     Document Type: Article

References (44)

1. Kreiss, K., M. M. Mroz, B. Zhen, H. Wiedemann, and B. Barna. 1997, Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup. Environ. Med. 54:605.
2. Maier, L. A., and L. S. Newman. 1998, Beryllium disease. In Environmental and Occupational Medicine. W. N. Rom, ed. Lippincott Williams & Wilkins, Philadelphia, p. 1017.
3. Newman, L. S., R. Balkissoon, E. Daniloff, M. Solida, and M. Mroz. 1998. Rate of progression from beryllium sensitization to chronic beryllium disease is 9-19% per year. Am. J. Respir. Crit. Care Med. 157: A145.
4. Mroz, M. M., K. Kreiss, D. C. Lezotte, P. A. Campbell, and L. S. Newman. 1991. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J. Allergy Clin. Immunol. 88:54.
5. Newman, L. S. 1996. Significance of the blood beryllium lymphocyte proliferation test (BeLPT). Environ. Health Perspect. 104:953.
6. Saltini, C., K. Winestock, M. Kirby, P. Pinkston, and R. G. Crystal. 1989. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N. Engl. J. Med. 320:1103.
7. Fontenot, A. P., B. L, Kotzin, C. L. Comment, and L. S. Newman. 1998. Expansions of T cell subsets expressing particular T cell receptor variable regions in chronic beryllium disease. Am. J. Respir. Cell Mol. Biol. 18:581.
8. Fontenot, A., M. Falta, L. Newman, and B. Kotzin. 1999. Identification of pathogenic T cells in patients with beryllium-induced lung disease. J. Immunol. 163:1029.
9. Fontenot, A. P., L. A. Maier, S. J. Canavera, T. B. Hendry-Hofer, M. Boguniewicz, E. A. Barker, L. S, Newman, and B. L. Kotzin. 2002. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. J. Immunol. 168:3627.
10. + T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. USA 97:12717.
11. Lombardi, G., C. Germain, J. Uren, M. T. Fiorillo, R. M. du Bois, W. Jones-Williams, C. Saltini, R. Sorrentino, and R. Lechler. 2001. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J. Immunol. 166:3549.
12. Parsons, C. E., R. T. Sawyer, L. Maier, M. M. Gillispie, and E. B. Gottschall. 2003. HLA-DP mediates beryllium-stimulated TNF-α in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 167:A579.
13. Richeldi, L.. R. Sorrentino, and C. Saltini. 1993. HLA-DPβ1 glutamate 69: a genetic marker of beryllium disease. Science 262:242.
14. 69 HLA-DPB 1 and -DPA 1 alleles. J. Immunol. 163:1647.
15. Maier, L. A., R. T. Sawyer, R. A. Bauer, L. A. Kittle, P. Lympany, D. McGrath, R. Dubois, E. Daniloff, C. S. Rose, and L. S. Newman. 2001. High beryllium-stimulated TNF-α is associated with the -308 TNF-α promoter polymorphism and with clinical severity in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 164:1192.
16. McConnochie, K., W. R. Williams, G. S. Kilpatrick, and W. Jones Williams. 1988. Chronic beryllium disease in identical twins. Br. J. Dis. Chest. 82:431.
17. Tarlo, S. M., K. Rhee, E. Powell, E. Amer, L. Newman, G. Liss, and N. Jones. 2001. Marked tachypnea in siblings with chronic beryllium disease due to copper-beryllium alloy. Chest 119:647.
18. Barna, B. P., S. D. Deodhar, T. Chiang, S. Gautam, and M. Edinger. 1984. Experimental beryllium-induced lung disease. I. Differences in immunologic response to beryllium compounds in strains 2 and 13 guinea pigs. Int. Arch. Allergy Appl. Immunol. 73:42.
19. Barna, B. P., S. D. Deodhar, S. Gautam, M. Edinger, T. Chiang, and J. T. McMahon. 1984. Experimental beryllium-induced lung disease. II. Analyses of bronchial lavage cells in strains 2 and 13 guinea pigs. Int. Arch. Allergy Appl. Immunol. 73:49.
20. Rossman, M. D., J. Stubbs, C. W. Lee, E. Argyris, E, Magira, and D. Monos. 2002. Human leukocyte antigen class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am. J. Respir. Crit. Care Med. 165:788.
21. Saltini, C., L. Richeldi, M. Losi, M. Amicosante, C. Voorter, E. van den Berg-Loonen, R. A. Dweik, H. P. Wiedemann, D. C. Deubner, and C. Tinelli. 2001. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur. Respir. J. 18:677.
22. Wang, Z., G. M. Farris, L. S. Newman, Y. Shou, L. A. Maier, H. N. Smith, and B. L. Marrone. 2001. Beryllium sensitivity is linked to HLA-DP genotype. Toxicology 165:27.
23. Martyny. J. W., M. D. Hoover, M. M. Mroz, K. Ellis, L. A. Maier, K. L. Sheff, and L. S. Newman. 2000. Aerosols generated during beryllium machining. J. Occup. Environ. Med. 42:8.
24. Kelleher, P. C., J. W. Martyny, M. M. Mroz, L. A. Maier, A. J. Ruttenber, D. A. Young, and L. S. Newman. 2001. Beryllium particulate exposure and disease relations in a beryllium machining plant. J. Occup. Environ. Med. 43:238.
25. Newman, L. S., M. M. Mroz, L. A. Maier, E. M. Daniloff, and R. Balkissoon. 2001. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J. Occup. Environ. Med. 43:231.
26. Maier. L. A., E. A. Barker, M. V. Raynolds, and L. S. Newman. 1999. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 159:1342.
27. Bunce, M., C. M. O'Neill, M. C. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence- specific primers (PCR-SSP). Tissue Antigens 46:355.
28. Gilchrist, F. C., M. Bunce, P. A. Lympany, K. I. Welsh, and R. M. du Bois. 1998. Comprehensive HLA-DP typing using polymerase chain reaction with sequence-specific primers and 95 sequence-specific primer mixes. Tissue Antigens 51:51.
29. Scott, B. L., Z. Wang, B. L. Marrone, and N. N. Sauer. 2003. Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study. J. Inorg. Biochem. 94:5.
30. Richeldi, L., K. Kreiss, M. M. Mroz, B. Zhen, P. Tartoni, and C. Saltini. 1997. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am. J. Ind. Med. 32:337.
31. McCanlies, E. C., K. Kreiss, M. Andrew, and A. Weston. 2003. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am. J. Epidemiol. 157:388.
32. + T cells in patients with chronic beryllium disease. J. Clin. Invest. 110:1473.
33. Maliarik, M. J., K, M. Chen, M. L. Major, R. G. Sheffer, J. Popovich, Jr., B. A. Rybicki, and M. C. Iannuzzi. 1998. Analysis of HLA- DPB1 polymorphisms in African-Americans with sarcoidosis. Am. J. Respir. Crit. Care Med 158:111.
34. Fontenot, A. P., L. S. Newman, and B. L. Kotzin. 2001. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP. Clin. Immunol. 100:4.
35. Martinetti, M., C. Tinelli, V. Kolek, M. Cuccia, L. Salaneschi, L. Parsturenzi, G. Semenzato, A. Cipriani, A. Bartova, and M. Luisetti. 1995. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am. J. Respir. Crit. Care Med. 152:557.
36. Berlin. M., A. Fogdell-Hahn, O. Olerup, A. Eklund, and J. Grunewald. 1997. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 156:1601.
37. Hanson, M. S., M. Cetkovic-Cvrlje, V. K. Ramiya, M. A. Atkinson, N. K. Maclaren, B. Singh, J. F. Elliott, D. V. Serreze, and E. H. Leiter. 1996. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J. Immunol. 157:1279.
38. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85:291.
39. Chao, C. C., H. K. Sytwu, E. L. Chen, J. Toma, and H. O. McDevitt. 1999. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. Proc. Nalt. Acad. Sci. USA 96:9299.
40. + lung and blood T cells in sarcoidosis. Am. J. Respir. Crit. Care Med. 163:115.
41. Schmidt, D., J. Verdaguer, N. Averill, and P. Santamaria, 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186:1059.
42. Rubin, R. L., and A. Kretz-Rommel. 2001. A nondeletional mechanism for central T-cell tolerance. Crit. Rev. Immunol. 21:29.
43. Kretz-Rommel, A., S. R. Duncan, and R. L. Rubin. 1997. Autoimmunity caused by disruption of central T cell tolerance: a murine model of drug-induced lupus. J. Clin. Invest. 99:1888.
44. Saltini, C., M. Kirby. B. C. Trapnell, N. Tamura, and R. B. Crystal. 1990. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J. Exp. Med. 171:1123.